Role of the dorsomedial hypothalamus in mediating the response to benzodiazepines on Trial 2 in the elevated plus-maze test of anxiety

Neuropsychopharmacology

Volumn 21, Issue 2, 1999, Pages 312-320

  File, Sandra E ^a   Gonzalez, Luis E ^a   Gallant, Rachael ^a  

^a NEUROSCIENCE RESEARCH CENTRE   (United Kingdom)

Author keywords

Anxiety; Benzodiazepines; Emotional Memory; Hypothalamus; Phobia; Plus maze

Indexed keywords

BENZODIAZEPINE RECEPTOR; CHLORDIAZEPOXIDE; LIDOCAINE;

ANIMAL EXPERIMENT; ANXIETY NEUROSIS; ARTICLE; BRAIN REGION; CONTROLLED STUDY; EMOTION; ESCAPE BEHAVIOR; HYPOTHALAMUS; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MAZE TEST; NONHUMAN; PHOBIA; PRIORITY JOURNAL; RAT; TRANQUILIZING ACTIVITY;

ANIMALS; ANTI-ANXIETY AGENTS; ANXIETY; CHLORDIAZEPOXIDE; DORSOMEDIAL HYPOTHALAMIC NUCLEUS; FUNCTIONAL LATERALITY; INFUSIONS, PARENTERAL; LIDOCAINE; MALE; MAZE LEARNING; MICROINJECTIONS; RATS;

EID: 0033011627     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(99)00028-7     Document Type: Article

References (52)

1. Bernardis L.L., Bellinger L.L. The dorsomedial hypothalamic nucleus revisited. An update Brain Res Rev. 12:1987;321-381.
2. Birbaumer N., Grodd W., Diedrich O., Klose U., Erb M., Lotze M., Schneider F., Weiss U., Flor H. fMRI reveals amygdala activation to human faces in social phobics. NeuroReport. 9:1998;1223-1226.
3. Brandao M.L., DiScala G., Bouchet M.J., Schmitt P. Escape behavior produced by the blockade of glutamic acid decarboxylase (GAD) in mesencephalic central gray or medial hypothalamus. Pharmacol Biochem Behav. 24:1986;496-501.
4. Fernandes C., File S.E. The influence of open arm ledges and maze experience in the elevated plus-maze. Pharmacol Biochem Behav. 54:1996;31-40.
5. File S.E. One-trial tolerance to the anxiolytic effects of chlordiazepoxide in the plus-maze. Psychopharmacology. 100:1990;281-282.
6. File S.E. The biological basis of anxiety. Meltzer H.Y., Nerozzi D. Current Practices and Future Developments in the Pharmacotherapy of Mental Disorders. 1991;159-165 Excerpta Medica, Amsterdam.
7. File S.E. The interplay of learning and anxiety in the elevated plus-maze. Behav Brain Res. 58:1993;199-202.
8. File S.E., Hitchcott P.K. A theory of benzodiazepine dependence that can explain whether flumazenil will enhance or reverse the phenomena. Psychopharmacology. 101:1990;525-532.
9. 1A receptor ligands in dorsal raphe and ventral hippocampus. Pharmacol Biochem Behav. 54:1996;123-128.
10. File S.E., Zangrossi H. "One-trial tolerance" to the anxiolytic actions of benzodiazepines in the elevated plus-maze, or the development of a phobic state? Psycho pharmacology. 110:1993;240-244.
11. File S.E., Andrews N., Hogg S. New developments in animal tests of anxiety. Westenberg H.G.M., Den Boer J.A., Murphy D.L. Advances in the Neurobiology of Anxiety Disorders. 1996;61-79 John Wiley & Sons, Chichester.
12. File S.E., Gonzalez L.E., Gallant R. Role of the basolateral nucleus of the amygdala in the formation of a phobia. Neuropsychopharmacology. 19:1998;397-405.
13. File S.E., Mabbutt P.S., Hitchcott P. Characterisation of the phenomenon of "one-trial tolerance" to the anxiolytic effect of chlordiazepoxide in the elevated plus-maze. Psychopharmacology. 102:1990;98-101.
14. File S.E., Zangrossi H., Viana M., Graeff F.G. Trial 2 in the elevated plus-maze. A different form of fear? Psychopharmacology. 111:1993;491-494.
15. File S.E., Zangrossi H., Sanders F.L., Mabbutt P.S. Raised corticosterone in the rat after exposure to the elevated plus-maze. Psychopharmacology. 113:1994;543-546.
16. Fredrikson M., Wik G., Annas P., Ericson K., Stone-Elander S. Functional neuroanatomy of visually elicited simple phobic fear. Additional data and theoretical analysis Psychophysiology. 32:1995;43-48.
17. Fuchs S.A.G., Siegel A. Neural pathways mediating hypothalamically elicited flight behavior in the cat. Brain Res. 306:1984;263-281.
18. Goisman R.M., Allsworth J., Rogers M.P., Warshaw M.G., Goldberg I., Vasile R.G., Rodriguez-Villa F., Mallya G., Keller M.B. Simple phobia as a comorbid anxiety disorder. Depression & Anxiety. 7:1998;105-112.
19. Gonzalez L.E., File S.E. A five minute experience in the elevated plus-maze alters the state of the benzodiazepine receptor in the dorsal raphe nucleus. J Neurosci. 17:1997;1505-1511.
20. Gonzalez L.E., Ouagazzal A.-M., File S.E. Stimulation of benzodiazepine receptors in the dorsal hippocampus and median raphé reveals a differential gabaergic control in two animal models of anxiety. Eur J Neurosci. 10:1998;3673-3680.
21. Graeff F.G. Minor tranquilisers and brain defense system. Braz J Med Biol Res. 14:1981;239-265.
22. Graeff F.G., Viana M.B., Mora P.O. Opposed regulation by dorsal raphe nucleus 5-HT pathways of two types of fear in the elevated T-maze. Pharmacol Biochem Behav. 53:1996;171-177.
23. Holmes A., Diffley E.P., Walton T.J., Brain P.F., Rodgers R.J. Lack of habituation of corticosterone response in mice repeatedly exposed to the plus-maze. J Psychopharmacol. 12:1998;A32.
24. Inglefield J.R., Schwartzkopf S.B., Kellogg C.K. Alterations in behavioral responses to stressors following exitotoxin lesions of dorsomedial hypothalamic regions. Brain Res. 633:1994;151-161.
25. A receptor in the cerebral cortex. A non-corticosterone influence Brain Res. 609:1993;244-252.
26. A receptor blockade in the dorsomedial hypothalamic nucleus on corticotrophin (ACTH) and corticosterone secretion in male rats. Brain Res. 739:1996;46-51.
27. Killcross S., Robbins T.W., Everitt B.J. Different types of fear-conditioned behaviour mediated by separate nuclei within amygdala. Nature. 388:1997;377-380.
28. LeDoux J.E., Iwata J., Cichetti P., Reis D.J. Different projections of the central amygdaloid nucleus mediate autonomic and behavioral correlates of conditioned fear. J Neurosci. 8:1988;2517-2529.
29. Lucey J.V., Costa D.C., Adshead G., Deahl M., Busatto G., Gacinovic S., Travis M., Pilowsky L., Ell P.J., Marks I.M., Kerwin R.W. OCD, panic disorder with agoraphobia, and post-traumatic stress disorder on 99 m TcHMPAD single photon emission tomography (SPET). Br J Psychiat. 171:1997;346-350.
30. Marks I.M. Fears, Phobias and Rituals. 1987;Oxford University Press, New York, NY.
31. McGaugh J.L., Cahill L., Roozendall B. Involvement of the amygdala in memory storage. interaction with other brain systems Proc Natl Sci USA. 93:1996;13508-13514.
32. Milani H., Graeff F.G. GABA-benzodiazepine modulation of aversion in the medial hypothalamus of the rat. Pharmacol Biochem Behav. 28:1987;21-27.
33. Packard M.G., McGaugh J.L. Inactivation of hippocampus or caudate nucleus with lidocaine differentially affects expression of place and response learning. Neurobiol Learn Mem. 65:1996;65-72.
34. Panksepp J. The psychoneurology of fear. evolutionary perspectives and the role of animal models in understanding human anxiety Burrows G.D., Roth M., Noyes R. Handbook of Anxiety. The Neurobiology of Anxiety:1990;3-58 Elsevier Science Publishers, Amsterdam, The Netherlands.
35. Parent M.B., McGaugh J.L. Post-training infusion of lidocaine into the amygdala basolateral complex impairs retention of inhibitory avoidance training. Brain Res. 661:1994;97-103.
36. Paxinos G., Watson C.H. The rat brain in stereotaxic coordinates. 1986;Academic Press, London, UK.
37. Pellow S., Chopin P., File S.E., Briley M. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Meth. 14:1985;149-167.
38. Pesold C., Treit D. The septum and amygdala differentially mediate the anxiolytic effects of benzodiazepines. Brain Res. 638:1994;295-301.
39. Pesold C., Treit D. The central and basolateral amygdala differentially mediate the anxiolytic effects of benzodiazepines. Brain Res. 671:1995;213-221.
40. Rodgers R.J., Johnson N.J.T. Factor analysis of spatiotemporal and ethological measures in the murine elevated plus-maze test of anxiety. Pharmacol Biochem Behav. 52:1995;297-303.
41. Rodgers R.J., Shepherd J.K. Influence of prior maze experience on behaviour and response to diazepam in the elevated plus-maze and light/dark tests of anxiety in mice. Psychopharmacology. 113:1993;237-242.
42. Rodgers R.J., Lee C., Shepherd J.K. Effects of diazepam on behavioural and antinociceptive responses to the elevated plus-maze in male mice depend upon treatment regimen and prior maze experience. Psychopharmacology. 106:1992;102-110.
43. Salinas J.A., Packard M.G., McGaugh J.L. Amygdala modulates memory for change in reward magnitude. Reversible post-training inactivation with lidocaine attenuates the response to a reduction in reward Behav Brain Res. 59:1993;153-159.
44. Shekhar A. GABA receptors in the region of the dorsomedial hypothalamus of rats regulate anxiety in the elevated plus-maze test. I. Behavioral measures. Brain Res. 627:1993;9-16.
45. Shekhar A., Katner J.S. Dorsomedial hypothalamic GABA regulates anxiety in the social interaction test. Pharmacol Biochem Behav. 50:1995;253-258.
46. Shekhar A., Sims L.S., Bowsher R.R. GABA receptors in the region of the dorsomedial hypothalamus of rats regulate anxiety in the elevated plus-maze test. II. Physiological measures. Brain Res. 627:1993;17-24.
47. Swanson L.W. The hypothalamus. Bjorklund A., Hokfelt T., Swanson L.W. Handbook of Chemical Neuroanatomy, vol 5. 1987;1-104 Elsevier Science Publishers, Amsterdam, The Netherlands.
48. Taukulis H.K., McKay R.W. Postdrug retention of diazepam's effects on habituation to a novel environment in an animal model of anxiety. Behav Neural Biol. 53:1992;286-293.
49. Treit D., Menard J. Dissociations among the anxiolytic effects of septal, hippocampal and amygdaloid lesions. Behav Neurosci. 111:1997;653-658.
50. Treit D., Menard J., Royan C. Anxiogenic stimuli in the elevated plus-maze. Pharmacol Biochem Behav. 44:1993;463-469.
51. Tyrer P. Choice of treatment in anxiety. Tyrer P. Psychopharmacology of Anxiety. 1989;254-282 Oxford Medical Publications, Oxford, UK.
52. Wik G., Fredrikson M., Ericson K., Eriksson L., Stone-Elander S., Greitz T. A functional cerebral response to frightening visual stimulation. Psychiat Res Neuroimag. 50:1993;15-24.